.
  • NIFTY 24,712.05 -255.70 (-1.02%)
  • SENSEX 80,786.54 -849.37 (-1.04%)
 
BSE
NSE

Tuesday, August 26, 2025 , BSE Sensex : 80,786.54 80,786.54(-1.04%) , Adani Ports : 1,315.50 1,315.50(-1.85%) , Asian Paints : 2,487.45 2,487.45(-0.21%) , Axis Bank : 1,050.15 1,050.15(-1.86%) , Bajaj Finance : 876.50 876.50(-2.67%) , Bajaj Finserv : 1,924.20 1,924.20(-2.00%) , Bharat Electron : 365.85 365.85(-1.65%) , Bharti Airtel : 1,905.40 1,905.40(-1.31%) , Eternal Ltd : 317.80 317.80(-0.49%) , HCL Technologies : 1,492.25 1,492.25(-0.82%) , HDFC Bank : 973.05 973.05(-0.94%) , Hind. Unilever : 2,692.10 2,692.10(2.38%) , ICICI Bank : 1,416.70 1,416.70(-1.15%) , Infosys : 1,529.85 1,529.85(-0.18%) , ITC : 403.10 403.10(0.93%) , Kotak Mah. Bank : 1,965.30 1,965.30(-0.92%) , Larsen & Toubro : 3,539.60 3,539.60(-1.76%) , M & M : 3,330.90 3,330.90(-2.02%) , Maruti Suzuki : 14,711.30 14,711.30(1.75%) , NTPC : 333.25 333.25(-1.36%) , Power Grid Corpn : 279.80 279.80(-1.53%) , Reliance Industr : 1,385.30 1,385.30(-1.95%) , SBI : 807.80 807.80(-0.94%) , Sun Pharma.Inds. : 1,600.45 1,600.45(-3.40%) , Tata Motors : 681.55 681.55(-0.75%) , Tata Steel : 155.00 155.00(-2.88%) , TCS : 3,156.25 3,156.25(0.49%) , Tech Mahindra : 1,502.20 1,502.20(-1.61%) , Titan Company : 3,592.90 3,592.90(-1.62%) , Trent : 5,292.60 5,292.60(-2.45%) , UltraTech Cem. : 12,608.35 12,608.35(0.03%) ,

Nifty 50 : 24,712.05 -255.70(-1.02%) , Adani Enterp. : 2,272.00 -30.90(-1.34%) , Adani Ports : 1,315.40 -25.00(-1.87%) , Apollo Hospitals : 7,793.50 -57.50(-0.73%) , Asian Paints : 2,481.40 -11.50(-0.46%) , Axis Bank : 1,050.10 -19.90(-1.86%) , Bajaj Auto : 8,691.50 -59.00(-0.67%) , Bajaj Finance : 876.25 -24.55(-2.73%) , Bajaj Finserv : 1,924.20 -39.60(-2.02%) , Bharat Electron : 365.85 -6.20(-1.67%) , Bharti Airtel : 1,904.70 -26.00(-1.35%) , Cipla : 1,579.80 -21.40(-1.34%) , Coal India : 372.45 -7.55(-1.99%) , Dr Reddy's Labs : 1,263.20 -20.70(-1.61%) , Eicher Motors : 6,151.00 160.50(2.68%) , Eternal Ltd : 317.90 -1.35(-0.42%) , Grasim Inds : 2,796.20 -15.20(-0.54%) , HCL Technologies : 1,492.80 -11.40(-0.76%) , HDFC Bank : 973.40 -8.65(-0.88%) , HDFC Life Insur. : 776.60 -10.40(-1.32%) , Hero Motocorp : 5,073.40 9.60(0.19%) , Hind. Unilever : 2,692.60 61.00(2.32%) , Hindalco Inds. : 705.70 -10.15(-1.42%) , ICICI Bank : 1,416.60 -16.60(-1.16%) , IndusInd Bank : 756.40 -14.45(-1.87%) , Infosys : 1,529.60 -2.50(-0.16%) , ITC : 403.35 4.00(1.00%) , Jio Financial : 315.75 -3.95(-1.24%) , JSW Steel : 1,047.10 -10.70(-1.01%) , Kotak Mah. Bank : 1,965.70 -17.60(-0.89%) , Larsen & Toubro : 3,541.30 -61.80(-1.72%) , M & M : 3,330.80 -68.10(-2.00%) , Maruti Suzuki : 14,714.00 262.00(1.81%) , Nestle India : 1,162.20 9.20(0.80%) , NTPC : 333.20 -4.65(-1.38%) , O N G C : 234.19 -2.57(-1.09%) , Power Grid Corpn : 279.90 -4.25(-1.50%) , Reliance Industr : 1,384.90 -27.70(-1.96%) , SBI : 807.85 -8.60(-1.05%) , SBI Life Insuran : 1,816.60 -30.20(-1.64%) , Shriram Finance : 594.70 -26.15(-4.21%) , Sun Pharma.Inds. : 1,600.30 -56.40(-3.40%) , Tata Consumer : 1,079.90 -1.70(-0.16%) , Tata Motors : 681.65 -5.15(-0.75%) , Tata Steel : 155.03 -4.60(-2.88%) , TCS : 3,157.20 16.60(0.53%) , Tech Mahindra : 1,502.20 -24.90(-1.63%) , Titan Company : 3,594.00 -57.40(-1.57%) , Trent : 5,295.00 -128.00(-2.36%) , UltraTech Cem. : 12,610.00 4.00(0.03%) , Wipro : 252.03 -1.81(-0.71%) , Tuesday, August 26, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
13-Aug-2025     10:30
Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets

The approval covers strengths of 2.5 mg, 10 mg, 15 mg, and 20 mg. The approved tablets are bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Xarelto Tablets, manufactured by Janssen Pharmaceuticals, Inc.

The product will be manufactured at Indoco's facility in Verna Industrial Area, Goa (L-14, Verna, Goa ' 403722).

Rivaroxaban is an oral anticoagulant used for the treatment and prevention of venous thromboembolism (VTE) ' a serious condition involving blood clots in the veins, which can lead to complications such as pulmonary embolism.

Commenting on the development, Aditi Panandikar, managing director of Indoco Remedies, said, 'Besides reflecting the capability of Indoco Remedies to deliver products of high-quality standards, this development also provides impetus to our growth aspirations in an important market such as the US.'

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).

The company had reported a consolidated net loss of Rs 40.39 crore in the quarter ended March 2025 as against net profit of Rs 22.70 crore during the previous quarter ended March 2024. Sales declined by 12.57% to Rs 383.89 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News